CA1198054A - Dialysis method and apparatus - Google Patents
Dialysis method and apparatusInfo
- Publication number
- CA1198054A CA1198054A CA000404895A CA404895A CA1198054A CA 1198054 A CA1198054 A CA 1198054A CA 000404895 A CA000404895 A CA 000404895A CA 404895 A CA404895 A CA 404895A CA 1198054 A CA1198054 A CA 1198054A
- Authority
- CA
- Canada
- Prior art keywords
- dialysate
- osmolarity
- solution
- sodium ion
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
The invention relates to an improved method of performing a hemodialysis treatment which includes the steps of providing a dialyzer having a blood flow com-partment separated from a dialysate flow compartment by a semi-permeable membrane, conducting blood to be dialyzed through the blood flow compartment, and conducting a dialysate solution through the dialysate flow compartment.
The improvement comprises the step of varying the osmo-larity of the dialysate solution non-linearly as a function of time during at least a portion of the total time used for the treatment. The improved method of the invention helps to alleviate the symptoms of, and the problems associated with, dialysis disequilibrium syndrome.
The invention relates to an improved method of performing a hemodialysis treatment which includes the steps of providing a dialyzer having a blood flow com-partment separated from a dialysate flow compartment by a semi-permeable membrane, conducting blood to be dialyzed through the blood flow compartment, and conducting a dialysate solution through the dialysate flow compartment.
The improvement comprises the step of varying the osmo-larity of the dialysate solution non-linearly as a function of time during at least a portion of the total time used for the treatment. The improved method of the invention helps to alleviate the symptoms of, and the problems associated with, dialysis disequilibrium syndrome.
Description
8~
Dialysis Method And Apparatus Field Of The Invention This invention relates to a method and apparatus for per--forming hemodialysis. More particularly, the invention relates to method and apparatus for performing hemodialy-sis in which the osmolarity of the dialysis fluid varies, non-linearly as a function of time during at least a portion of the total time used for the treatment cycle.
Background Of The Invention The use of dialysis to treat patients with kidney~ disease is well-known. The treatment involves the use of an artificial kidney dialyzer which is a device comprising a first compartment for the flow of blood to be dialyzed and a second compartment for the flow of an aqueous dialysis fluid (or "dialysate" as it is sometimes called). The two compartments are separated from one another in the device by a semipermeable membrane suitable for the dialysis procedure. Such semiperrneable membranes are commercially available and are made from, for example, regenerated cuprammonium cellulose or cellulose acetate. The semi-permeable membranes may be used in kidney dialyzers in theform of sheet, tubing or hollow fibers.
In its broadest aspect, hemodialysis involves withdrawing blood from a patient and passing that blood through the blood flow compartment of the artificial kidney while at the same time passing aqueous dialysis fluid through the dialysate compartment. As the blood flows through the dialy~er, impurities such as urea and creatinine are transported throuyh the semipermeable membrane and are dissolved in the dialysate. Cleansed blood exiting the dialy%er is returned to the patient, ~hile the dialysate ~,
Dialysis Method And Apparatus Field Of The Invention This invention relates to a method and apparatus for per--forming hemodialysis. More particularly, the invention relates to method and apparatus for performing hemodialy-sis in which the osmolarity of the dialysis fluid varies, non-linearly as a function of time during at least a portion of the total time used for the treatment cycle.
Background Of The Invention The use of dialysis to treat patients with kidney~ disease is well-known. The treatment involves the use of an artificial kidney dialyzer which is a device comprising a first compartment for the flow of blood to be dialyzed and a second compartment for the flow of an aqueous dialysis fluid (or "dialysate" as it is sometimes called). The two compartments are separated from one another in the device by a semipermeable membrane suitable for the dialysis procedure. Such semiperrneable membranes are commercially available and are made from, for example, regenerated cuprammonium cellulose or cellulose acetate. The semi-permeable membranes may be used in kidney dialyzers in theform of sheet, tubing or hollow fibers.
In its broadest aspect, hemodialysis involves withdrawing blood from a patient and passing that blood through the blood flow compartment of the artificial kidney while at the same time passing aqueous dialysis fluid through the dialysate compartment. As the blood flows through the dialy~er, impurities such as urea and creatinine are transported throuyh the semipermeable membrane and are dissolved in the dialysate. Cleansed blood exiting the dialy%er is returned to the patient, ~hile the dialysate ~,
2--containina the impurities removed from the blood is recirculated or discarded.
The dialysate comprises an aqueous solution of electro-lytes which is prepared, either on a batch basis or continuously, by dissolving the electrolytes in water or by diluting a concentrated aqueous solution of the electrolytes (called a "dialysate concentrate") with water. In either case, the "standard" dialysate customar-ily usecl to carry out the dialysis treatment has a fixedcomposition which typically comprises about 136 milli-equivalents per liter (meq./l.) of sodium ion, about
The dialysate comprises an aqueous solution of electro-lytes which is prepared, either on a batch basis or continuously, by dissolving the electrolytes in water or by diluting a concentrated aqueous solution of the electrolytes (called a "dialysate concentrate") with water. In either case, the "standard" dialysate customar-ily usecl to carry out the dialysis treatment has a fixedcomposition which typically comprises about 136 milli-equivalents per liter (meq./l.) of sodium ion, about
3.5 meq./l.'of calcium ion, about 1.5 meqO/l. of magnesium ion, about 2.6 meq./l of potassium ionl about 15 106.6 meqO/l. of chloride ion, and about 37 meq/l. of acetate ion. (In some instances, part or all of the acetate ion may be replaced by bicarbonate ion).
Since, as is well known, the conductivity of an aqueous solution of electrolytes is a function of the concentra-tion of electrolytes dissolved therein, it is possible to ascertain whether the desired concentration of electro-lytes is present in the dialysate being supplied to the dialysate cornpartment by measuring the conductivity of the -~ 25 dialysate. Thus a hemodialysis system typically comprises a conductivity cell which is placed in the dialysate line between the source of dialysate and the inlet to the dialysate compartment and which continuously monitors the conductivity of~the entering dialysate. The conductivity cell has three electrodes uniformly spaced in an epoxy casing. Two of these electrodes are wired together inter-nally and exit the cell body at a "common" terminal; the third of the electrodes exits the cell at a "signal"
terminal. The conductivity cell is part of a conductivity monitor circuit which is designed to create a small voltage between the cell's "signal" and "common" terni-ECP 5~
7~
The amount of the flow of electrons which results fromthis voltage will depend upon the conductivity of the dialysate solution flowing through the conductivity cell.
In the event the rneasured conductivity of the dialysate is more than a fixed amount, e.g. 5~, above or below the desired conductivity, the monitor circuit automatically sends a signal to its associated logic circuitry which, in turn, produces an alarm (either audible or visual or both) indicating that the dialysate conductivity limits have been exceeded. Since conductivity is also temperature dependent it is common practice to include a thermistor in the conductivity circuit. This thermistor, which is located on t`he inlet side of the conductivity cell, continuously feeds dialysate temperature information to the conductivity monitor circuit, thus allowing that circuit to compensate for any changes in dialysate temperature. Thus it will be seen that the conductivity cell measures the dialysate conductivity on a continuous basis and sounds an alarm if that conductivity deviates more or less than a fixed amount from a constant conductivity value.
A patient with kidney disease is typically on a treatment schedule in which his blood is dialyzed every third day, ' 25 the duration of the treatment varying on the order of from about three to about five hours~ At the beginning of a treatment, the sodium ion level in the patient's blood is elevated and is in the range of 145~146 meq./liter. In what is regarded as a standard dialysis treatment, the patient's blood is dialyzed against the aforementioned, fixed composition standard dialysate, which has a sodiurn ion concentration of 136 meq./liter. Tl-le composition of the dialysate solution, and hence the osmolarity, is ~ept constallt for the c]uration of the treatment cycle. Thus, .CP SG
- 'I -as illustrated in FIG. l, the sodium ion concentration in the patient's blood is gradually reduced so that at the end of the treatment, the blood sodium concentration has been reduced to a level which is approximately equal to the dialysate sodium concentration. The osmolarity of the patient's blood has also been reduced as a result of the removal therefrom of both ionized and non-ionized waste products during the dialysis treatment. In the time prior to his next scheduled treatment, the sodium ion level in the patient's blood gradually increases so that just prior to the start of the next treatment, it has reached the elevated level of 1~5-146 meq.~liter.
The increase- in sodium ion, along with increases in the concentration of non-ionizable waste products, re~sults in a corresponding increase in the patient's blood osmolarity.
It has been observed that patients who are dialyzed after a lay-off of several days exhibit what is known as "dialysis disequilibrium syndrome", that is, the patient suffers from such symptoms as nausea, headache, and vomitinq. Dialysis disequilibrium syndrome is thought to be related to the large difference between the total blood osmolarity of the patient at the outset of the dialysis -~ 25 treatment compared to the total osmolarity of the dialysate being used.
It has been proposed in order to alleviate dialysis disequilibrium syndrome that the sodium ion concentration 3~ in the dialysate be increased which in turn increases the total dialysate osrnolarity. In one approach, illustrated in E~IG. 2, "high sodium dialysatc" is used for the duration of the treatment. The dialysate solution used in this "lligh sodium dialysate" approach has a sodium ion concentration of about 155 meq./liter as a result of which its osmolarity is significantly higher than the ; CP 56 36~
--5~
total blood osmolarity of the patient at the start of the treatment. It will be understood that this approach does not involve any change in the osmolarity of the dialysate during the treatment; the osmolarity of the dialysate is maintained constant throughout the treatment cycle although at a level which is higher than the osmolarity of the aforementioned standard dialysate. While this approach appears to have enjoyed some success in relieving dialysis disequilibrium syndrome and does not interfere with the removal from the blood of such impurities as urea and creatinine, it su-ffers from the serious disadvantage that during the dialysis treatment cycle, the sodium ion level in the` patient's blood increasesl whereas one of the purposes of dialysis is to reduce such sodium levelsO In addition, such elevation in blood sodium level tends to make the patient thirsty, and he desires to drink water to alleviate that thirst at precisely the time when it is desired to reduce the patient's body water content via ultrafiltration during the dialysis procedure.
In a second approach to alleviating the dialysis disequi-librium syndrome problem, a supplementary aqueous sodium ion solution (e.g., a solution of sodium chloride in water) is used in conjunction with the aforementioned "standard" dialysate solution having a fixed composition.
In this approach, standard dialysate is continuously fed to the dialysate compartment in the usual way, and the supplementary aqueous sodium ion solution is added at a linearly decreasing rate for an initial portion of the treatrnent time and at a constant rate for the remainder of the treatment time. Thus, the osmolarity of the dialysate flowing through the dialysate compartment of the dialyzer is linearly reduced during the initial stages of the dialysis treatment cycle. As an example of the second approach, and assuming the patient's tota] blood sodiurn lcvel at the ou~set of the treatment to bc 145 meq./l., ECE' 56 the supplementary aqueous sodium ion solution is added to the dialysate (136 meq./l. Na~) at an initial rate such that the dialysate which initially flows through the dialyzer has a sodium ion concentration of about 155 meq./l. The rate of addition of the supplementary sodium ion solution to the standard dialysate solution is then continuously reduced on a linear basis so that, by the end of an initial portion (e.g., one hour) of the total dialy-sis treatment cycle time, the overall concentration of sodium ion in the dialysate has approached the customarily used level of about 136 meq.~l. At that point, the addi-tion of the supplementary sodium ion is discontinued (or, if it is desired to keep the feed line flushed, kept at a constant, extremely low rate) so that the sodium ion level ]5 in the dialysate for the remainder of the treatment time is held substantially constant at the customary level of about 136 meq./l. See FIG. 3. The disadvantages of this second approach are similar, though perhaps not so severe, to those encountered with the first described approach.
During the initial stages of the dialysis treatent the total dialysate osmolarity is undesirably and disadvanta-geously higher than the patient's total blood osrnolarity.
The patient's blood sodium level rises sharply during the first thirty minutes of the treatment instead of falling as is desirable. The patient still experiences thirst and desires to take in water at exactly the time when his water content is supposed to be reduced or at least held constant.
In accordance with the present invention there is provided an improved method for dialyzing blood. The improved method helps to alleviate the symptoms of, and the problems associated with, dialysis disequilibrium syndrome ancl is characterized by the fact that the osmolarity of thc dialysate supplied to the dialysate chambcr of an artificial ~.idney is varied non--linearly as a functior. of ~CP 56 ~ t3~
time during at least a portion of the total time used for the dialysis treatment cycle. In a specific embodiment of the improved method, the osmolarity of a standard dialysate solution is varied by varying the concentration of sodium ion in the dialysate solution in accordance with the equation:
y = [Ut-U(t-8)] 100 sin n t + [~(t-8)-~(t-17~1 (- t3 + 12.5t2 - 150t -~ 628.33) + [U(t-17)-U(t-60)]
(-t-~70) + [U(t-60)]10 where y - the concentration of sodium ion in the dialysate, t is the time in minutes and U is a Unit Step Function.
O~
A preferred method according to the present invention employs the standard fixed composition dialysate solution described earlier herein, and a supplementary aqueous solution of sodium ion. The supplementary solution preferably consists of sodium chloride dissolved in water.
A 10% by weight solution of sodium chloride in water has been found suitable-, although other concentrations of sodium chloride may be used. Similarly, other ionizable sodium salts may be used in place of sodium chloride. The osmolarity of the dialysate flowing through the dialysate compartment of the dialyzer is varied on a non-linear basis during the first part of the treatment cycle. The length of this first part of time during which the dialysate osmolarity is varied on a non-linear basis may be, for example, one, two, or three hours. AEter the first part of the total treatment time has been completed, the osmolarity of the dialysate is preferably decreased linearly until it approaches thc osmolarity of standard dialysate. From that point in time unt:il the treatment is cornpleted, the osmolarity o~ the dialysate is maintained substantially constant at its standard level.
Example I
Following is an example of a dialysis treatment in which the osmolarity of the dialysate is varied non-linearly during the first hour of a five-hour treatment and is maintained substantially constant for the last four hours. During the first hour of the treatment, the dialysate supplied to the dialysate chamber of the dialy~er consists of a mixture of the earlier-described s~andard dialysate solution having a fixed composition and a supplementary aqueous solution of 10~ by weight sodiurn chloride. The osmolarity of the supplied dialysate is varied by varying the sodium ion concentration therein. The sodium ion concentration in the supplied dialysate is varied by changing the amount of the supplementary solution which is mixed with the standard dialysate.
A patient having kidney disease is set up in the usual fashion for a dialysis treatment. Blood to be dialyzed is taken from the patient, pumped through a blood dialyzer, and returned to the patient as usual. An aqueous solution consisting of 136 meq/l. Na+, 106.6 meq./l. Cl-, 3.5 meq./l. Ca~2, 1.5 meq./l. Mg~2, 2.6 meq./l. K-~, and 37 -~ 25 meq./l. of acetate ion is used as the standard dialysate of fixed composition. A solution of 10~ by weight of sodium chloride in water is used as the supplernentary aqueous sodium ion solution, this solution containing 380 rneq./l. sodium ion. The standard dialysate solution and the supplementary solution are kept in separate reservoirs and are pumped to a mixing point on the inlet side of the dialysate chamber usinq any suitable pumping means. The standard dialysate is purnped at a rate of 0.5 liters/
minute. The patient to be treated has a total blood sodiurm level at the start of the treatmeIlt of about 145-1~6 meq./l. At thc? ouLsct of the treat;nent and for ~P 56 _9_ approximately three minutes thereafter, the supplementary solution is added to the standard dialysate at such a rate that the sodium ion concentration in the mixed dialysate entering the dialyzer rises to a value of about 155 meq./l. It will be observed that the sodium ion concer,tration in the mixed dialysate (and, corresponding-ly, the osmolarity) at this point in the treatment cycle is considerably in excess of the initial sodium ion concentration of the patient's blood. Subsequently, the rate of addition of the supplementary solution is reduced so that after about 10 minutes from the start of the treatment, the sodium ion concentration in the mixed dialysate is about 145 meq./l. At the end of the same ten minu-te period, the sodium ion level in the patient's blood has increased to a level of approximately 150 meq./l. It will be observed that, at this point in the treatment cycle, the sodium ion level in (and, correspondingly, the osmolarity of) the mixed dialysate is decreasingl while the sodium ion concentration of the patient's blood is increasing. It should further be noted that at this point in time the sodium level in the mixed dialysate is less than the sodium ion level in the patient's blood. The rate of addition of the supplementary solution is then increased and during the next 6 minutes of the treatment cycle, the sodium ion concentration in the mixed dialysate reaches 148 meq./l. while the sodium ion concentration in the blood reaches a level of 152 meq./l.
As a result of the foregoing procedure, the peak value of the sodium ion in the blood is minimized during the first thirty minutes o the treatmerlt. 'rhe time lag between the increase in sodium ion level in the dialysate and the subsequ~nt increase in the sodium ion level in the blood is significant in holding the peak levels of sodium ion in the blood to a minimum. Subsequently, the rate of addition of the ,ul)plementary solution is reduced L.~P 5~
5~
gradually and on a linear basis until the sodium ion concentration in the dialysate supplied to the dialyzer approaches 136 meq./liter which is the sodium ion concen-tration in the standard, fixed composition dialysate. At that time, the addition of the supplementary solution is substantially discontinued (if desired, the addition of the supplementary solution may be continued at a neyli-gible rate in order to keep the feed lines flushed3 and the sodium ion concentration in the dialysate (and hence the osmolarity of the dialysate) is held substantially constant for the remainder of the treatment cycle.
It will be u`nderstood that a variation in the sodium ion level in the dialysate effects a corresponding va~riation in the dialysate osmolarity, that is, a higher sodium ion level produces a higher osmolarity and a lower sodium ion level produces lower osmolarity. FIG. 4 shows the non-linear variation of the sodium ion level in the dialysate during the initial stages of the treatment, the subse-quent linear decrease in concentration o~ the sodium ionin the dialysate in the intermediate stages of the treatment, and the constant level of sodium ion in the dialysate during the final stages of the treatment.
Since the osmolarity is a direct function of the sodium ion level, the osmolarity of the dialysate likewise varies non-linearly, then decreases linearly, and thereafter holds constant for the remainder of the treatment.
Since, as is well known, the conductivity of an aqueous solution of electrolytes is a function of the concentra-tion of electrolytes dissolved therein, it is possible to ascertain whether the desired concentration of electro-lytes is present in the dialysate being supplied to the dialysate cornpartment by measuring the conductivity of the -~ 25 dialysate. Thus a hemodialysis system typically comprises a conductivity cell which is placed in the dialysate line between the source of dialysate and the inlet to the dialysate compartment and which continuously monitors the conductivity of~the entering dialysate. The conductivity cell has three electrodes uniformly spaced in an epoxy casing. Two of these electrodes are wired together inter-nally and exit the cell body at a "common" terminal; the third of the electrodes exits the cell at a "signal"
terminal. The conductivity cell is part of a conductivity monitor circuit which is designed to create a small voltage between the cell's "signal" and "common" terni-ECP 5~
7~
The amount of the flow of electrons which results fromthis voltage will depend upon the conductivity of the dialysate solution flowing through the conductivity cell.
In the event the rneasured conductivity of the dialysate is more than a fixed amount, e.g. 5~, above or below the desired conductivity, the monitor circuit automatically sends a signal to its associated logic circuitry which, in turn, produces an alarm (either audible or visual or both) indicating that the dialysate conductivity limits have been exceeded. Since conductivity is also temperature dependent it is common practice to include a thermistor in the conductivity circuit. This thermistor, which is located on t`he inlet side of the conductivity cell, continuously feeds dialysate temperature information to the conductivity monitor circuit, thus allowing that circuit to compensate for any changes in dialysate temperature. Thus it will be seen that the conductivity cell measures the dialysate conductivity on a continuous basis and sounds an alarm if that conductivity deviates more or less than a fixed amount from a constant conductivity value.
A patient with kidney disease is typically on a treatment schedule in which his blood is dialyzed every third day, ' 25 the duration of the treatment varying on the order of from about three to about five hours~ At the beginning of a treatment, the sodium ion level in the patient's blood is elevated and is in the range of 145~146 meq./liter. In what is regarded as a standard dialysis treatment, the patient's blood is dialyzed against the aforementioned, fixed composition standard dialysate, which has a sodiurn ion concentration of 136 meq./liter. Tl-le composition of the dialysate solution, and hence the osmolarity, is ~ept constallt for the c]uration of the treatment cycle. Thus, .CP SG
- 'I -as illustrated in FIG. l, the sodium ion concentration in the patient's blood is gradually reduced so that at the end of the treatment, the blood sodium concentration has been reduced to a level which is approximately equal to the dialysate sodium concentration. The osmolarity of the patient's blood has also been reduced as a result of the removal therefrom of both ionized and non-ionized waste products during the dialysis treatment. In the time prior to his next scheduled treatment, the sodium ion level in the patient's blood gradually increases so that just prior to the start of the next treatment, it has reached the elevated level of 1~5-146 meq.~liter.
The increase- in sodium ion, along with increases in the concentration of non-ionizable waste products, re~sults in a corresponding increase in the patient's blood osmolarity.
It has been observed that patients who are dialyzed after a lay-off of several days exhibit what is known as "dialysis disequilibrium syndrome", that is, the patient suffers from such symptoms as nausea, headache, and vomitinq. Dialysis disequilibrium syndrome is thought to be related to the large difference between the total blood osmolarity of the patient at the outset of the dialysis -~ 25 treatment compared to the total osmolarity of the dialysate being used.
It has been proposed in order to alleviate dialysis disequilibrium syndrome that the sodium ion concentration 3~ in the dialysate be increased which in turn increases the total dialysate osrnolarity. In one approach, illustrated in E~IG. 2, "high sodium dialysatc" is used for the duration of the treatment. The dialysate solution used in this "lligh sodium dialysate" approach has a sodium ion concentration of about 155 meq./liter as a result of which its osmolarity is significantly higher than the ; CP 56 36~
--5~
total blood osmolarity of the patient at the start of the treatment. It will be understood that this approach does not involve any change in the osmolarity of the dialysate during the treatment; the osmolarity of the dialysate is maintained constant throughout the treatment cycle although at a level which is higher than the osmolarity of the aforementioned standard dialysate. While this approach appears to have enjoyed some success in relieving dialysis disequilibrium syndrome and does not interfere with the removal from the blood of such impurities as urea and creatinine, it su-ffers from the serious disadvantage that during the dialysis treatment cycle, the sodium ion level in the` patient's blood increasesl whereas one of the purposes of dialysis is to reduce such sodium levelsO In addition, such elevation in blood sodium level tends to make the patient thirsty, and he desires to drink water to alleviate that thirst at precisely the time when it is desired to reduce the patient's body water content via ultrafiltration during the dialysis procedure.
In a second approach to alleviating the dialysis disequi-librium syndrome problem, a supplementary aqueous sodium ion solution (e.g., a solution of sodium chloride in water) is used in conjunction with the aforementioned "standard" dialysate solution having a fixed composition.
In this approach, standard dialysate is continuously fed to the dialysate compartment in the usual way, and the supplementary aqueous sodium ion solution is added at a linearly decreasing rate for an initial portion of the treatrnent time and at a constant rate for the remainder of the treatment time. Thus, the osmolarity of the dialysate flowing through the dialysate compartment of the dialyzer is linearly reduced during the initial stages of the dialysis treatment cycle. As an example of the second approach, and assuming the patient's tota] blood sodiurn lcvel at the ou~set of the treatment to bc 145 meq./l., ECE' 56 the supplementary aqueous sodium ion solution is added to the dialysate (136 meq./l. Na~) at an initial rate such that the dialysate which initially flows through the dialyzer has a sodium ion concentration of about 155 meq./l. The rate of addition of the supplementary sodium ion solution to the standard dialysate solution is then continuously reduced on a linear basis so that, by the end of an initial portion (e.g., one hour) of the total dialy-sis treatment cycle time, the overall concentration of sodium ion in the dialysate has approached the customarily used level of about 136 meq.~l. At that point, the addi-tion of the supplementary sodium ion is discontinued (or, if it is desired to keep the feed line flushed, kept at a constant, extremely low rate) so that the sodium ion level ]5 in the dialysate for the remainder of the treatment time is held substantially constant at the customary level of about 136 meq./l. See FIG. 3. The disadvantages of this second approach are similar, though perhaps not so severe, to those encountered with the first described approach.
During the initial stages of the dialysis treatent the total dialysate osmolarity is undesirably and disadvanta-geously higher than the patient's total blood osrnolarity.
The patient's blood sodium level rises sharply during the first thirty minutes of the treatment instead of falling as is desirable. The patient still experiences thirst and desires to take in water at exactly the time when his water content is supposed to be reduced or at least held constant.
In accordance with the present invention there is provided an improved method for dialyzing blood. The improved method helps to alleviate the symptoms of, and the problems associated with, dialysis disequilibrium syndrome ancl is characterized by the fact that the osmolarity of thc dialysate supplied to the dialysate chambcr of an artificial ~.idney is varied non--linearly as a functior. of ~CP 56 ~ t3~
time during at least a portion of the total time used for the dialysis treatment cycle. In a specific embodiment of the improved method, the osmolarity of a standard dialysate solution is varied by varying the concentration of sodium ion in the dialysate solution in accordance with the equation:
y = [Ut-U(t-8)] 100 sin n t + [~(t-8)-~(t-17~1 (- t3 + 12.5t2 - 150t -~ 628.33) + [U(t-17)-U(t-60)]
(-t-~70) + [U(t-60)]10 where y - the concentration of sodium ion in the dialysate, t is the time in minutes and U is a Unit Step Function.
O~
A preferred method according to the present invention employs the standard fixed composition dialysate solution described earlier herein, and a supplementary aqueous solution of sodium ion. The supplementary solution preferably consists of sodium chloride dissolved in water.
A 10% by weight solution of sodium chloride in water has been found suitable-, although other concentrations of sodium chloride may be used. Similarly, other ionizable sodium salts may be used in place of sodium chloride. The osmolarity of the dialysate flowing through the dialysate compartment of the dialyzer is varied on a non-linear basis during the first part of the treatment cycle. The length of this first part of time during which the dialysate osmolarity is varied on a non-linear basis may be, for example, one, two, or three hours. AEter the first part of the total treatment time has been completed, the osmolarity of the dialysate is preferably decreased linearly until it approaches thc osmolarity of standard dialysate. From that point in time unt:il the treatment is cornpleted, the osmolarity o~ the dialysate is maintained substantially constant at its standard level.
Example I
Following is an example of a dialysis treatment in which the osmolarity of the dialysate is varied non-linearly during the first hour of a five-hour treatment and is maintained substantially constant for the last four hours. During the first hour of the treatment, the dialysate supplied to the dialysate chamber of the dialy~er consists of a mixture of the earlier-described s~andard dialysate solution having a fixed composition and a supplementary aqueous solution of 10~ by weight sodiurn chloride. The osmolarity of the supplied dialysate is varied by varying the sodium ion concentration therein. The sodium ion concentration in the supplied dialysate is varied by changing the amount of the supplementary solution which is mixed with the standard dialysate.
A patient having kidney disease is set up in the usual fashion for a dialysis treatment. Blood to be dialyzed is taken from the patient, pumped through a blood dialyzer, and returned to the patient as usual. An aqueous solution consisting of 136 meq/l. Na+, 106.6 meq./l. Cl-, 3.5 meq./l. Ca~2, 1.5 meq./l. Mg~2, 2.6 meq./l. K-~, and 37 -~ 25 meq./l. of acetate ion is used as the standard dialysate of fixed composition. A solution of 10~ by weight of sodium chloride in water is used as the supplernentary aqueous sodium ion solution, this solution containing 380 rneq./l. sodium ion. The standard dialysate solution and the supplementary solution are kept in separate reservoirs and are pumped to a mixing point on the inlet side of the dialysate chamber usinq any suitable pumping means. The standard dialysate is purnped at a rate of 0.5 liters/
minute. The patient to be treated has a total blood sodiurm level at the start of the treatmeIlt of about 145-1~6 meq./l. At thc? ouLsct of the treat;nent and for ~P 56 _9_ approximately three minutes thereafter, the supplementary solution is added to the standard dialysate at such a rate that the sodium ion concentration in the mixed dialysate entering the dialyzer rises to a value of about 155 meq./l. It will be observed that the sodium ion concer,tration in the mixed dialysate (and, corresponding-ly, the osmolarity) at this point in the treatment cycle is considerably in excess of the initial sodium ion concentration of the patient's blood. Subsequently, the rate of addition of the supplementary solution is reduced so that after about 10 minutes from the start of the treatment, the sodium ion concentration in the mixed dialysate is about 145 meq./l. At the end of the same ten minu-te period, the sodium ion level in the patient's blood has increased to a level of approximately 150 meq./l. It will be observed that, at this point in the treatment cycle, the sodium ion level in (and, correspondingly, the osmolarity of) the mixed dialysate is decreasingl while the sodium ion concentration of the patient's blood is increasing. It should further be noted that at this point in time the sodium level in the mixed dialysate is less than the sodium ion level in the patient's blood. The rate of addition of the supplementary solution is then increased and during the next 6 minutes of the treatment cycle, the sodium ion concentration in the mixed dialysate reaches 148 meq./l. while the sodium ion concentration in the blood reaches a level of 152 meq./l.
As a result of the foregoing procedure, the peak value of the sodium ion in the blood is minimized during the first thirty minutes o the treatmerlt. 'rhe time lag between the increase in sodium ion level in the dialysate and the subsequ~nt increase in the sodium ion level in the blood is significant in holding the peak levels of sodium ion in the blood to a minimum. Subsequently, the rate of addition of the ,ul)plementary solution is reduced L.~P 5~
5~
gradually and on a linear basis until the sodium ion concentration in the dialysate supplied to the dialyzer approaches 136 meq./liter which is the sodium ion concen-tration in the standard, fixed composition dialysate. At that time, the addition of the supplementary solution is substantially discontinued (if desired, the addition of the supplementary solution may be continued at a neyli-gible rate in order to keep the feed lines flushed3 and the sodium ion concentration in the dialysate (and hence the osmolarity of the dialysate) is held substantially constant for the remainder of the treatment cycle.
It will be u`nderstood that a variation in the sodium ion level in the dialysate effects a corresponding va~riation in the dialysate osmolarity, that is, a higher sodium ion level produces a higher osmolarity and a lower sodium ion level produces lower osmolarity. FIG. 4 shows the non-linear variation of the sodium ion level in the dialysate during the initial stages of the treatment, the subse-quent linear decrease in concentration o~ the sodium ionin the dialysate in the intermediate stages of the treatment, and the constant level of sodium ion in the dialysate during the final stages of the treatment.
Since the osmolarity is a direct function of the sodium ion level, the osmolarity of the dialysate likewise varies non-linearly, then decreases linearly, and thereafter holds constant for the remainder of the treatment.
Claims (11)
1. In a method for supplying dialysate solution to a dialyzer having a dialysate flow compartment defined by a semipermeable membrane wherein the dialysate solution flows through said dialysate flow compartment for a period of time, the improvement which comprises the step of varying the osmolarity of said dialysate solution nonlinearly as a function of time during at least a portion of the total time of flow of said dialysate solution through said dialysate flow compartment.
2. A method according to claim 1, wherein said dialysate solution is formed by mixing a dialysate solution of fixed composition with a supplementary solution comprising an ionizable substance.
3. A method according to claim 1, wherein said supplementary solution is an aqueous solution of sodium chloride.
4. A method according to claim 1, wherein during an initial portion, the osmolarity of said dialysate reaches a first maximum value, thereafter reaches a first minimum value, and then reaches a second maximum value, said second maximum value being less than said first maximum value.
5. A method according to claim 4, wherein after the osmolarity of said dialysate reaches said second maximum value, said osmolarity is decreased linearly to a second minimum value which is lower than said first minimum value.
6. A method according to claim 5, wherein the osmolarity of said dialysate is maintained sub-stantially constant at said second minimum value for the remaining portion of said treatment.
7. In a method for supplying dialysate solution to a dialyzer having a dialysate flow compartment defined by a semipermeable membrane wherein the dialysate solution flows through said dialysate flow compartment, the improvement which comprises varying the concentration of sodium ion in the dialysate according to the equation where y = the concentration of sodium ion, t is the time in minutes, and U is a Unit Step Function.
8. Apparatus for performing a hemodialysis treatment, comprising a dialyzer having a first com-partment for the flow of blood to be dialyzed and a second compartment for the flow of dialysate, the two compartments being separated from one another by a semipermeable membrane, means being provided for conducting blood to be dialyzed through the first com-partment, means also being provided for conducting dialysate through the second compartment, and means further being provided for varying the osmolarity of the dialysate non-linearly as a function of time whereby (in use of the apparatus) that osmolarity is varied non-linearly as a function of time during at least a portion of the total treatment time.
9. Apparatus according to claim 8, wherein the osmolarity varying means employ a standard dialysate reservoir and a supplementary solution reservoir, and pumping means whereby (in use of the apparatus) the standard dialysate and supplementary solution are pumped from their respective reservoirs to a mixing point on the inlet side of the said second compartment.
10. Apparatus according to claim 9, incorporating an osmolarity varying means control system designed to vary the osmolarity of the dialysate in a predetermined non-linear mode in an initial stage, to decrease the osmolarity linearly in an intermediate stage, and to keep the osmolarity substantially constant in a final stage, the said non-linear mode being characterized by an increase to a first maximum, a subsequent de-crease to a first minimum, and a subsequent increase to a second maximum less than the first maximum.
11. Apparatus according to claim 10, wherein the control system employs dialysate osmolarity or sodium ion concentration monitoring means operatively coupled with the said pumping means to effect those variations in the proportion of supplementary solution mixed with the standard dialysate whereby the requisite variations in osmolarity are obtained.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27263381A | 1981-06-11 | 1981-06-11 | |
| US272,633 | 1981-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1198054A true CA1198054A (en) | 1985-12-17 |
Family
ID=23040632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000404895A Expired CA1198054A (en) | 1981-06-11 | 1982-06-10 | Dialysis method and apparatus |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA1198054A (en) |
| GB (1) | GB2100144B (en) |
-
1982
- 1982-06-10 GB GB8216936A patent/GB2100144B/en not_active Expired
- 1982-06-10 CA CA000404895A patent/CA1198054A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB2100144A (en) | 1982-12-22 |
| GB2100144B (en) | 1986-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6284141B1 (en) | Method and system for preventing intradialytic symptomatology | |
| Lornoy et al. | Remarkable removal of beta-2-microglobulin by on-line hemodiafiltration | |
| US6117100A (en) | Hemodialysis-double dialyzers in parallel | |
| EP1450879B2 (en) | Method of priming a dialysis machine | |
| Lin et al. | Long-term on-line hemodiafiltration reduces predialysis beta-2-microglobulin levels in chronic hemodialysis patients | |
| JP4159250B2 (en) | Method and apparatus for calculating dialysis efficiency | |
| US6620120B2 (en) | Method for high efficiency hemofiltration | |
| US3939069A (en) | Artificial kidney and a method of ultrafiltering a liquid | |
| US4722798A (en) | Hemodialysis with dialysate osmolarity varied non-linearly with time | |
| RU2020970C1 (en) | Artificial kidney | |
| JP2002521162A (en) | Efficient hemodiafiltration | |
| US7942842B2 (en) | Apparatus and method for the treatment of blood | |
| EP1347822A1 (en) | Two stage diafiltration method and apparatus | |
| JPH04220264A (en) | Blood refiner for treatment and manufacture of transfusion for hemodialysis filtration | |
| JP2002520096A (en) | Method for determining dialysance and apparatus for the method | |
| CA1198054A (en) | Dialysis method and apparatus | |
| JPS59115051A (en) | Blood purifying apparatus | |
| JPS58155864A (en) | Blood purifying apparatus | |
| JPH06114102A (en) | Blood dialysis and filtration device | |
| Heineken et al. | Prescribing dialysate bicarbonate concentrations for hemodialysis patients | |
| JP3413985B2 (en) | Selective separation membrane and blood processing apparatus using the same | |
| JPH03215270A (en) | Blood treatment apparatus | |
| JPH06233813A (en) | Hemocatharsis system | |
| Maeda et al. | Hernodiafiltration With Sodium Concentration‐Controlled Dialysate | |
| Koda | Internal filtration-enhanced hemodialysis is a cost-effective treatment in view of solute removal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |